Journal of the American Heart Association

Article	Citations
Level of Perivascular Inflammation Is Significantly Lower Around the Left Internal Mammary Artery Than Around Native Coronary Arteries	225
Understanding Participant Perspectives Toward the Formation of a Participant Advisory Board Within the Reasons for Geographic and Racial Differences in Stroke Study: A National Qualitative Study	209
Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS	197
Do Individuals With Inherited Cardiac Diseases Experience Reproductive Decision‐Making Guilt?	190
CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes	190
Clinical Metabolomic Landscape of Cardiovascular Physiology and Disease	184
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy	164
Editors and Editorial Board	162
Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease	158
Bench to all Bedsides in Genomics and Precision Medicine	158
Left Ventricular Outflow Tract Morphology as a Predictor of Conductance Disturbances Following Transcatheter Aortic Valve Replacement	152
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020	140
Multi‐Trait Polygenic Risk Score, Nongenetic Determinants, and Cardiovascular Disease Death: A Cohort Study of 14 086 Japanese Individuals	139
Comparison of Centers for Disease Control and Prevention and Hospital‐Based Stroke Mortality Data in Kentucky: The Paul Coverdell National Acute Stroke Program	132
Myocardial Infarction Across COVID‐19 Pandemic Phases: Insights From the Veterans Health Affairs System	131
Discrimination Between Pre‐ and Postcapillary Pulmonary Hypertension Using Platelet RNA	128
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold‐Standard Clinical Models in Multiethnic Populations	127
Contributions of Women to Cardiovascular Science Over Two Decades: Authorship, Leadership, and Mentorship	127
Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women	124
Racial and Ethnic Disparities in the Medical Management of Poststroke Complications Among Patients With Acute Stroke	120
Contributions of Germline and Somatic Mosaic Genetics to Thoracic Aortic Aneurysms in Nonsyndromic Individuals	118
Correction to: Racial and Ethnic Differences in the Association between Classical Cardiovascular Risk Factors and Common Carotid Intima‐Media Thickness: An Individual Participant Data Meta‐Analysis	114
Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease	110
Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results	109
Correction to: Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway	108

Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease	107
Saliva, Plasma, and Multifluid Metabolomic Signatures of Periodontal Disease, Type 2 Diabetes Progression, and Markers of Glycemia and Dyslipidemia Among Puerto Rican Adults With Overweight and Obesit	105
Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer	100
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction	89
Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS	88
Co‐Occurrence of Social Risk Factors and Associated Outcomes in Patients With Heart Failure	87
Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention	86
Protective Effect on Spinal Cord Injury of Prophylactic Cerebrospinal Fluid Drainage in Extensive Aortic Arch Repair for Type A Aortic Dissection: A Retrospective Cohort Study	85
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score	85
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion	80
Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis	79
Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries	78
Sociodemographic and Clinical Characteristics and Self‐Care Behaviors Are Associated With Shared Decision‐Making in Adults With Hypertension	77
Early Alteration of Right Ventricle–Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction	76
Prevalence of Mitral Annulus Disjunction and Mitral Valve Prolapse in Patients With Idiopathic Ventricular Fibrillation	75
Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction	74
Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J‐PCI Registry	73
Door‐to‐Needle Time for Extracorporeal Cardiopulmonary Resuscitation and Neurological Outcomes in Out‐of‐Hospital Cardiac Arrest: A Nationwide Study	71
Culprit Lesion Vessel Size and Risk of Reperfusion Injury in ST‐Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study	71
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial	71
Metabolic Syndrome and Efficacy of Remote Ischemic Postconditioning in Acute Moderate Ischemic Stroke: A Post Hoc Analysis of the RICAMIS Trial	70
Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy	69
Trends in Blood Pressure Control During the COVID‐19 Pandemic: A Study of 17 US Health Systems in the National Patient‐Centered Clinical Research Network Blood Pressure Control Laboratory	69
Immune Markers, Blood Pressure Severity, and Cardiac Remodeling 1 to 2 Years After Hypertensive Disorders of Pregnancy	69
Factors Influencing Quality Improvement Success in Primary Care: A Comparative Case Study of High‐ and Low‐Performing Sites in Patient Hypertension Outcomes	68
Contemporary Valvular Mechanisms of Aortic Regurgitation in Tricuspid Aortic Valves: Importance in Repair Versus Replacement Strategy	68
Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction	66
Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes	66
Contribution of Conventional Cardiovascular Risk Factors to Brain White Matter Hyperintensities	65
Differential Characteristics and Outcomes of Urgent/Emergent Versus Elective Aortic Valve Replacement	65
Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE‐HF	64
Novel Size‐Based High‐Density Lipoprotein Subspecies and Incident Vascular Events	63
Recommendations in Extracorporeal Cardiopulmonary Resuscitation Post Resuscitation Care Via An International, Modified Delphi Approach	63
QRS Fragmentation in Preserved Ejection Fraction Heart Failure: Functional Insights, Pathological Correlates, and Prognosis	62
Subendocardial Viability Ratio Is Associated With Target Organ Damage and Hints at a Potential Independent Predictor of Cardiovascular Mortality in Older Adults: A Prospective Cohort Study	62
Monocyte Chemoattractant Protein‐1, Inflammatory Biomarkers, and Prognosis of Patients With Ischemic Stroke or Transient Ischemic Attack: Fndings From a Nationwide Registry Study	62
Day‐to‐Day Blood Pressure Variability and Risk of Incident Chronic Kidney Disease in a General Japanese Population	61
Ross Procedure Versus Mechanical Versus Bioprosthetic Aortic Valve Replacement: A Network Meta‐Analysis	61
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long‐Term Variability	60
Correction to: Comparison of Effectiveness Among Different Sodium‐Glucose Cotransporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials	59
Subclass‐Specific Impact of β 1 ‐Adrenergic Receptor Autoantibodies and Phenotype‐Specific Interaction With β‐Blockers in a Contemporary Population W	58
Defining Spiritual Wellbeing in Survivors of Stroke: A Convergent Parallel Mixed Methods Study	58
Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium	58
Mitophagy in Macrophages: A Metabolic Checkpoint in Inflammation‐to‐Repair Transition in Atherosclerosis	58
Survival Benefit of Heart–Kidney Versus Heart Transplant With or Without Delayed Kidney Transplant	58
Number of Live Births as a Protective Factor Against Clinical and Covert Brain Infarcts: The Framingham Heart Study	57
Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial	56
Heart Failure–Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020	56
Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction	53
Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid	53

Inpatient‐Onset Versus Outpatient‐Onset ST‐Segment–Elevation Myocardial Infarction in Patients With Percutaneous Coronary Intervention: A National Registry Study	53
Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry	53
Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis	52
Ultrafast Cooling With Total Liquid Ventilation Mitigates Early Inflammatory Response and Offers Neuroprotection in a Porcine Model of Cardiac Arrest	52
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction	52
Challenges in Assessing Stroke Incidence in Low‐ and Middle‐Income Countries	52
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry	52
External Validation of Published Scoring Systems to Predict Incident Atrial Fibrillation After Cryptogenic Stroke/Embolic Stroke of Undetermined Source	51
Cross‐Sectional Relationships of Proximal Aortic Stiffness and Left Ventricular Diastolic Function in Adults in the Community	51
Clinical Benefits of Medical Therapy in Adults With Congenital Heart Disease and Systemic Left Ventricular Presenting With Heart Failure With Reduced Ejection Fraction	51
Dysphagia: A Novel Risk Factor for Poor Outcomes Following Cardiovascular Procedures	51
Multiomics Insights Into the Role of Spondin‐1 in the Pathogenesis and Prognosis of Atrial Fibrillation	51
Positive Predictive Value of International Classification of Diseases, Ninth Revision, Clinical Modification , and International Classification of Disease	51
Interaction of Extreme Temperature Events and Nitrogen Dioxide on Out‐of‐Hospital Cardiac Arrest in a Subtropical Megacity: A Time‐Series Analysis	51
Value‐Based Medicine in the Management of Abdominal Aortic Aneurysms	51
Beyond Traditional Risk Factors: The Role of Mental Health and Intersectionality in Cardiovascular Disease Risk Prediction Models	51
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression	50
Burden of Hyperlipidemia, Cardiovascular Mortality, and COVID‐19: A Retrospective‐Cohort Analysis of US Data	49
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program	49
Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes t	49
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance	49
Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes	49
AhR, IRF5, and HO‐1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study	48
Left Ventricular Ejection Fraction Change Following Percutaneous Coronary Intervention: Correlates and Association With Prognosis	48
Multiethnic Perspectives of Shared Decision‐Making in Hypertension: A Mixed‐Methods Study	48
Association of Hypertension With Early‐Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case–Control Study	48
Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR	48
SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling	47
Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development	47
Real‐Time Ambulatory ECG Does Not Expedite Care	47
Supranormal Ejection Fraction in Heart Failure: Exploring the Heterogeneity of a Distinct Clinical Phenotype	46
Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?	46
Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study	46
Cardiovascular Risk Estimation Is Suboptimal in People With HIV	46
Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study	46
Resource Use Following Revascularization for Multivessel Coronary Artery Disease	46
Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population‐Based Investigation	46
Right Ventricular–Pulmonary Artery Uncoupling and Strain in Acute Heart Failure	46
Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease	46
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF	45
Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure	45
microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery	45
Randomized, Placebo‐Controlled, Triple‐Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline‐Based Cancer Therapy	45
Association Between Maternal Factors in Early Pregnancy and Congenital Heart Defects in Offspring: The Japan Environment and Children's Study	45
Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients	45
Association Between Pulse Pressure and Structural Brain Changes in Aging: A Systematic Review and Meta‐Analysis of Cross‐Sectional and Longitudinal Studies	45
Eighteen‐Year Trends in Motor Recovery During Inpatient Rehabilitation After Ischemic Stroke	44
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure	44
Association Between Life's Simple 7 and Biomarkers of Cardiovascular Disease: Aldosterone, Interleukin‐6, C‐Reactive Protein	44
Body Mass Index in Adolescence and Long‐Term Risk of Early Incident Atrial Fibrillation and Subsequent Mortality, Heart Failure, and Ischemic Stroke	44
White Matter Hyperintensities: Complex Predictor of Complex Outcomes	43
Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study	43
Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review	43
Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice	43
Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men	43
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	43
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcom	43
Neuroprotective Effect of Melatonin in a Neonatal Hypoxia–Ischemia Rat Model Is Regulated by the AMPK/mTOR Pathway	43
Associations Between Metabolic Score for Visceral Fat and Venous Thromboembolism Among 118 619 Participants With Metabolic Syndrome: Insights From Epidemiology to Genetic Susceptibility	43
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study	42
Obese Male Mice Exposed to Early Life Stress Display Sympathetic Activation and Hypertension Independent of Circulating Angiotensin II	42
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States	42
Medication Adherence, Blood Pressure Variability, and Mild Cognitive Impairment	42
Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention	42
Left‐Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention Registry	41
Association Between Physical Activity Dose and Mental Health Among Stroke Survivors	41
County Incarceration Rate and Stroke Death: A Cross‐Sectional Study of the Influence of Physical Environment, Health Care Access, and Community Mental Distress	41
Correction to: Gelatin Methacryloyl Bioadhesive Improves Survival and Reduces Scar Burden in a Mouse Model of Myocardial Infarction	41
Reduced Fetuin‐A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac–Hepatic–Peripheral Interaction	41
Long‐Term Clinical‐Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy	41
Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention	41
Identifying High‐Risk Cardiac Arrest Neighborhoods Using Social Vulnerability Index and Geospatial Analysis	41
Association of Longitudinal High‐Sensitivity Cardiac Troponin T With Clinical Outcomes in Adult Heart‐Transplant Recipients	40
Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Systemic Right Ventricles: Incrementally Building the Evidence Base	40
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators	40
Prospective Observational Study for the Comparison of Screening Methods Including Tongue Pressure and Repetitive Saliva Swallowing With Detailed Videofluoroscopic Swallowing Study Findings in Patients	40
Renal Denervation Improves Uremic Cardiomyopathy in Rats With Chronic Kidney Disease	40
Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study	40
Mediators of Cardiovascular and Renal Outcomes: How Do Novel Diabetes Medications Work?	40
Effect of Combination Antihypertensive Pills on Blood Pressure Control	39

Race and Resuscitation: Taking the Next Steps	39
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure	39
Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization	39
Within‐Physician Differences in Patient Sharing Between Primary Care Physicians and Cardiologists Who Treat White and Black Patients With Heart Disease	39
Nuclear Receptor Subfamily 4 Group A Member 1 Exacerbates Cardiac Remodeling by Inhibiting Mitochondrial Function Through the Peroxisome Proliferator‐Activated Receptor γ Coactivator‐1α/Nuclear Respir	39
Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement	39
Transcatheter Aortic Valve Implantation in Elderly Patients With Aortic Valve Stenosis: The Role of Frailty, Malnutrition, and Sarcopenia	38
High Self‐Reported Levels of Pain 1 Year After a Myocardial Infarction Are Related to Long‐Term All‐Cause Mortality: A SWEDEHEART Study Including 18 376 Patients	38
Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study	38
Correction to: Role of Resilience in the Psychological Recovery of Women With Acute Myocardial Infarction	38
Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression	38
Was COVID‐19 Associated With Worsening Inequities in Stroke Treatment and Outcomes?	38
Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction	38
Genetic Determinants of Left Atrial Function Are Associated With Stroke	38
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension	38
Association Between Hypertension and Diabetes Control and COVID‐19 Severity: National Patient‐Centered Clinical Research Network, United States, March 2020 to February 2022	38
Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke	38
CD1d‐Dependent Natural Killer T Cells Mediate Hypertension and Vascular Injury Through Interleukin‐17A	38
Cerebrovascular Disease Detected on Preprocedural Computed Tomography in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement	38
Associations of Baseline and Changes in Intrinsic Capacity With Incident Cardiovascular Disease: A Multicohort Study	37
Social Determinants of Cardiovascular Health in US Adolescents: National Health and Nutrition Examination Surveys 1999 to 2014	37
Correction to: Long‐Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long‐Term Survival Study (PEARLS)	37
Consensus‐Based Development of a Pediatric Echocardiography Complexity Score: Design, Rationale, and Results of a Quality Improvement Collaborative	37
Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience	37
Real‐World Evidence Linking the Predicting Risk of Cardiovascular Disease Events Risk Score and Coronary Artery Calcium	37
Genetic‐Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations	36
Ninety‐Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Strok	36
Prevalence of Cerebral Microbleeds and Association With Vascular Risk Factors in a Hispanic and Latino American Cohort	36
Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial	36
Yield on Reinterpretation of Genetic Variants in Pediatric Cardiomyopathy	36
Cardiogenic Shock Complicating Takotsubo Syndrome: Sex‐Related Differences	36
Perioperative Metabolites Are Associated With Adverse Neonatal Congenital Heart Disease Surgical Outcomes	36
Cerebral Small‐Vessel Disease Markers on Magnetic Resonance Imaging as Predictors of Recurrent Vascular Events and Death in Ischemic Stroke: A Systematic Review and Meta‐Analysis	36
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level	36
Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study	36
Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing	35
Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation	35
Association of Home‐Based Cardiac Rehabilitation With Lower Mortality in Patients With Cardiovascular Disease: Results From the Veterans Health Administration Healthy Heart Program	35
Inflammatory Markers and Stroke Outcomes: Lessons From Neutrophil Counts and Antiplatelet Therapy	35
Congenital Heart Disease, Atrial Fibrillation, and Ischemic Stroke Risk	35
Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta‐Analysis	35
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease	35
New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure	35
Relative Cerebral Blood Flow as an Indirect Imaging Surrogate in Patients With Anterior Circulation Large Vessel Occlusion and Association of Baseline Characteristics With Poor Collateral Status	34
Modulation of Abnormal Vasoconstriction Through 2‐Hydroxyisobutyrylation of Tropomyosin 3 Lys141: Targeting Histone Deacetylase 3 as a Key Approach	34
Identification of Centrosome Duplication‐Related Biomarkers in Hypertrophic Cardiomyopathy Through Integrative Multi‐Omics, Single‐Cell Transcriptomics, and Experimental Validation	34
Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and Management	34
Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity	34
Cardiovascular Health Characterization Using Life's Essential 8 Score in Perimenopausal Women: An Analysis of the National Health and Nutritional Examination Survey	34
Acid–Base Status During Venoarterial Extracorporeal Membrane Oxygenator Support in Patients With Cardiogenic Shock	34
Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats	34
From Artificial Intelligence to Quantum Computing: Promise and Prudence in the Field of Cardiovascular Medicine	34
Impella‐Protected High‐Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity	34
Long‐Term Adherence to Modifiable Factors and Incident Cardiovascular Disease Among Women With a History of Gestational Diabetes: A Prospective Cohort Study	34
Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults	34
Retinal Microvasculature and Emotional, Behavioral, and Cognitive Outcomes at School Age	34
Association of Higher Dietary Omega‐3 Fatty Acid Intake With Cardiovascular‐Kidney‐Metabolic Syndrome Stage Severity and Mortality in US Adults: A Cross‐Sectional and Prospective Cohort Analysis of NH	34
Role of GLP‐1 Receptor Agonists in Managing Cancer Therapy–Related Cardiac Dysfunction	33
Impact of Sex‐ and Gender‐Related Factors on Length of Stay Following Non–ST‐Segment–Elevation Myocardial Infarction: A Multicountry Analysis	33
Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented	33
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents	33
Impact of Left Ventricular Diastolic Pressure Changes on Clinical Outcomes After Transcatheter Aortic Valve Replacement	33
Alert‐Triggered Patient Education Versus Nurse Feedback for Nonadministered Venous Thromboembolism Prophylaxis Doses: A Cluster‐Randomized Controlled Trial	33
Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study	33
Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	33
Patient‐Specific Computational Flow Simulation Reveals Adverse Hemodynamic Factors Associated With Occlusion of Directional Branches After Fenestrated‐Branched Endovascular Aneurysm Repair	33
Association Between Triglyceride–Glucose Index and Carotid Plaque Stability in Different Glycemic Status: A Single‐Center Retrospective Study	33
Hypoxia Attenuates Pressure Overload‐Induced Heart Failure	33
Balancing Days at Home and Major Adverse Limb Events After Surgical Versus Endovascular Lower‐Extremity Revascularization in Chronic Kidney Disease	33
Invasive Strategy With Intended Percutaneous Coronary Intervention Versus Conservative Treatment in Older People With ST‐Segment–Elevation Myocardial Infarction: A Meta‐Analysis	33
Clinical Benefit of Thrombectomy in Large‐Core Infarction Patients Is Mediated by Malignant Cerebral Edema Reduction	33
Effect of Time Delay on Reperfusion After Tenecteplase in an Extended Time Window: Analysis From the CHABLIS‐T Trials	33
Clinical Outcomes of Diffuse Angiogram‐Negative Subarachnoid Hemorrhage Versus Aneurysmal Subarachnoid Hemorrhage: A Propensity Score‐Matched Analysis	33
Quality of Life and Well‐Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study	32
Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease	32
Macrophage‐Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction	32
Intracranial Atherosclerosis Disease Associated With Cognitive Impairment and Dementia: Systematic Review and Meta‐Analysis	32
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner	32
Macrophage Ferroptotic Resistance Is Required for the Progression of Infantile Hemangioma	32
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes	32
Clinical Outcome Prediction Model in Tetralogy of Fallot Without Pulmonary Valve Replacement Using Contraction Fraction From the SCOUT‐TOF Registry	32
Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke	32
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis	32
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA‐R Inverse Probability Weighted Analysis	32
Validation of the GERAADA Score for Predicting 30‐Day Mortality Rate in Acute Type A Aortic Dissection: A Single‐Center Study in China	31
Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018	31
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes	31
Sex‐Based Differences in Selected Cardiac Implantable Electronic Device Use: A 10‐Year Statewide Patient Cohort	31
Inflammation‐Derived and Clinical Indicator‐Based Predictive Model for Ischemic Stroke Recovery	31
Impact of Social Vulnerability on Cardiac Arrest Mortality in the United States, 2016 to 2020	31
Atrial Fibrillation After Patent Foramen Ovale Closure: Incidence, Pathophysiology, and Management	31
Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease	31
Asymptomatic Intracerebral Hemorrhage Following Endovascular Stroke Therapy Is Not Benign: A Systematic Review and Meta‐Analysis	31
Influence of the Social Environment on Ideal Cardiovascular Health	31
Predictive Value of Traditional and Novel Obesity Indices for Stroke and Its Subtypes Across Sexes and Glucose Status: Toward Precision Prevention Strategies	30